Introduction
Most neuropeptides are intercellular signalling molecules that interact with cell surface receptors to trigger an intracellular transduction pathway. There is huge diversity in peptidic signalling molecules, with well over 200 having been identified in arthropods alone. Not only are they structurally diverse, but also the signalling cascades that they trigger are highly varied and, ultimately, can have a multitude of effects on living cells, from stimulation of ion channel opening to suppression of transcriptional events.
Neuropeptides most probably pre-date the 'classical' neurotransmitters such as acetylcholine (ACh) and 5-hydroxytryptamine (5-HT, serotonin) in that neuropeptide signalling is believed to have evolved prior to that of the classical transmitters (Shaw, 1996; Walker et al., 1996) . Classical transmitters have long been recognized as playing an important role in neuronal communication, helped largely by the fact that, relative to the diversity displayed by neuropeptides, they are few in number. Moreover, understanding of the role(s) of neuropeptides is often hindered by the absence of primary sequence information, in that not all of the peptide signalling molecules have been identified and structurally characterized. Also, peptide effects are often subtle, slow in onset and long lasting, making them more difficult to identify and analyse.
The evolution of understanding of the roles of classical neurotransmitters versus those of neuropeptides is perhaps best displayed by research in nematodes. For many years, cutting-edge research on the physiology of nematodes focused on the actions of the classical ©CAB International 2001. Parasitic Nematodes (eds M.W. Kennedy and W. Harnett) neurotransmitters, ACh and γ-aminobutyric acid (GABA) (Del Castillo et al., 1963 , 1964 Martin, 1980; Stretton et al., 1985 Stretton et al., , 1992 Martin et al., 1991) . Using the large gastrointestinal pig nematode, Ascaris suum, models of nematode neuromuscular activity and locomotory behaviour, based on the tonic release of ACh and GABA, were developed (Stretton et al., 1985) . Although these models are still valid today, they take no account of the influence of endogenous neuropeptides on nematode locomotory behaviour. This omission was, of course, not deliberate; it was based on the premise that classical transmitters dominated the coordination of nematode behaviour, to the extent that the need for neuropeptide modulation in neuromuscular control was not recognized.
Over the last decade, and triggered by the pioneering work of Stretton and co-workers, numerous nematode neuropeptide sequences have been deduced (Davis and Stretton, 1996) . This sequence information has arrived relatively slowly, due to the huge amount of effort required in tissue collection and the ultimate purification of enough peptide to facilitate structural characterization. However, the Caenorhabditis elegans genome sequencing project has rapidly provided details on all of the putative neuropeptides in a nematode. The information generated on neuropeptide diversity in C. elegans has revolutionized current understanding of nematode neurobiology; simply put, it has revealed a totally unexpected complexity in nematode nervous systems and has highlighted a basic ignorance of the neurobiology of an organism that has only 300 some neurones (Bargmann, 1998 ).
An ability to recognize and identify potential neuropeptides from the vast quantities of data deposited in the genome sequencing databases is necessarily biased by current perceptions of neuropeptide characteristics. In this respect, a very common feature of neuropeptides is the presence of a C-terminal amide moiety (Bradbury and Smyth, 1991) . The reasons that most neuropeptides exhibit this feature are not clear, but it is believed to improve peptide stability in the reduction of carboxypeptidase attack and to be involved in receptor recognition, such that the deamidation of neuropeptides commonly results in loss of function. Searches for novel neuropeptides, therefore, tend to concentrate on search strings comprising two or three C-terminal residues that characterize a known neuropeptide family, a glycyl residue (putative amidation site) and a dibasic cleavage site, usually KR (single basic residues can also occupy the C-terminal position of glycyl amide donor sites). Nevertheless, numerous putative neuropeptides have been identified in C. elegans and it is likely that many more await to be discovered.
Although understanding of nematode neuropeptide signalling systems is extremely limited, the last decade has seen the generation of a large body of information on nematode neuropeptide localization, structure and function. The diversity of peptides involved in this signalling system and the variety of action of the identified peptides is so huge that attempts to trawl the existing information can often be disjointed and confusing. In this respect, a number of useful recent reviews have examined the complexity of this system in nematodes (Halton et al., 1994; Geary et al., 1995 Geary et al., , 1999 Brownlee et al., 1996a; Davis and Stretton, 1996; Maule et al., 1996a,b,c; Day and Maule, 1999) . This chapter aims to present an up-to-date account of nematode neuropeptide systems and attempts to synthesize a rational approach to the development of this research area.
Neuropeptide Localization
The first evidence that neuropeptides occurred in nematodes arose indirectly from histochemical techniques to identify neurosecretory elements in the 1960s (Davey, 1966; Rogers, 1968) . The next major breakthrough was the identification of neuropeptide immunostaining in nematodes in the late 1980s (Li and Chalfie, 1986; Leach et al., 1987; Atkinson et al., 1988; Davenport et al., 1988) . At this time, the diversity of neuropeptide structure in higher organisms was recognized and had become an ever expanding field of study. These early studies indicated that neuropeptide immunoreactivity was abundant and widespread in nematode nervous systems. Furthermore, evidence for the occurrence of neuropeptides in nematodes was generated for a wide range of species, from free-living to plant-and animal-parasitic forms.
Since these early studies, immunolocalization of neuropeptides has been achieved with a huge array of antisera, all with differing specificities to known vertebrate and invertebrate peptide families (Stretton et al., 1991; Halton et al., 1994; Brownlee et al., 1996a; Davis and Stretton, 1996; Maule et al., 1996c) . The information generated indicated that neuropeptides were associated with all of the major neuronal systems in nematodes, including the ganglia, longitudinal nerve cords, motor neurones, interneurones and sensory neurones. Such evidence indicated a diversity in putative function for these neuropeptides. However, the diversity in epitopes identified by the antisera used should be viewed with some caution. Immunocytochemistry is based on a non-competitive antibodyantigen reaction such that there is great potential for non-specific interaction of the antisera employed and consequent false positive results. Therefore, it is unreliable to estimate the number of neuropeptides in nematodes solely by using immunocytochemical criteria. The actual number of neuropeptides present in nematodes can only be deduced from gene or primary sequence information. In this respect, the C. elegans genome sequencing project provides a great opportunity to evaluate neuropeptide diversity in nematodes.
Although immunocytochemical screening of neurochemical diversity provides only an indication that a neuropeptide may be present, antisera that interact specifically with known nematode neuropeptides are likely to provide useful information on peptide distribution (Sithigorngul et al., 1989) . Even so, when multiple related peptides are present, as is the case in nematodes (see later), the potential for antisera cross-reactivity with numerous peptides is high. Nevertheless, it is possible to generate information on the distribution of specific peptide families, with contrasting structural features, within the nematode nervous system.
Distribution of FMRFamide-related Peptides (FaRPs) in Nematodes
Easily the most widely studied peptide family in nematodes is the FMRFamide-related peptides (FaRPs). Originally, these were classed as having an F/Y-X-R-F.amide motif. However, with increasing reports of primary sequence diversity, most small peptides (= 20 amino acids) that possess a C-terminal R-F.amide, and that are not members of the neuropeptide Y (NPY) family (RXRF/Y.amide), are deemed to be FaRPs. A variety of FaRP-antisera have been used to immunostain nematodes. Moreover, a number of antisera raised against other peptide families (NPY family peptides and SALMF.amide) (Smart et al., 1992a; Brownlee et al., 1996b) were subsequently found to cross-react with nematode FaRPs, such that the immunostaining patterns obtained in nematodes using these can, at least in part, be attributed to endogenous FaRPs.
FaRP distribution in Ascaris suum
In the large enteric pig parasite, A. suum, FaRP-immunostaining has been detected in some 60% of its nervous system, including all of its major components (central, peripheral and enteric) and all neuronal classes (motor, sensory and interneurones). Furthermore, the majority of the ganglia associated with the circumpharyngeal nerve ring (the nematode brain) are FaRP-immunopositive (Table 20 .1). FaRP-immunostaining is also widespread in nerve fibres, including all the longitudinal nerve cords (ventral, dorsal, lateral and sublateral) and fibres innervating the pharynx, rectum and ovijector (Brownlee et al., 1993a (Brownlee et al., ,b, 1994 Fellowes et al., 1999) .
The interrelationships of the FaRP-immunopositive nerves with pharyngeal and ovijector muscle have been examined using dual wavelength detection confocal microscopy (Fellowes et al., 1999; R.A. Fellowes, D.W. Halton and A.G. Maule, Belfast, 1999, unpublished observations) (Figs 20.1 and 20.2) . In these studies, varicose nerve fibres, which were highly FaRP-immunoreactive, were identified in close association with the circular muscle fibres of the ovijector (Fig. 20.1 ). The varicose nature of these nerve fibres is a well-documented feature of peptidergic nerves and is believed to represent accumulations of secretory vesicles as they are transported, en masse, along nerve axons. Evidence for the occurrence of neuromuscular synapses requires further studies at the electron microscope level. In the pharynx, FaRP-immunopositive nerve fibres form a number of anastomosing networks which innervate regions of pharyngeal muscle (R.A. Fellowes, D.W. Halton and A.G. Maule, unpublished observations) (Fig. 20.2 ).
FaRP distribution in Caenorhabditis elegans
The availability of the complete neuronal map of C. elegans has greatly facilitated work on its nervous system (White et al., 1986) . Immunocytochemical FaRP-screens of the worm showed that some 30 neurones (approximately 10% of its nervous system) were FaRP-immunopositive (Schinkmann and Li, 1992) , a significant contrast to the situation in A. suum. Such a disparity in the level of immunostaining between these worms is difficult to explain and seems unlikely to be due to small differences in staining technique. Although the distribution of FaRPs in C. elegans is more restricted than that reported for A. suum, they have similarly been localized to motor, sensory and interneurones. The specific localization of individual FaRPs using immunocytochemical techniques has been restricted by the structural similarity of endogenous FaRPs, making antibody discrimination extremely difficult. It is also unknown if the various FaRP antisera employed in studies on nematodes cross-react with all of the endogenous FaRPs; if not, then reports of FaRP abundance in the nervous systems of nematodes will be underestimates.
Expression of the C. elegans FMRFamide-like peptide gene-1 (flp-1) has been demonstrated using flp-1-lacZ reporter constructs in transgenic Fellowes et al., 1999) . 
FaRP distribution in other nematodes
FaRP-immunostaining has been localized to the nervous system of a range of other nematode species, including free-living, animal parasitic and plant parasitic forms (Table 20 .2 and references therein). 
Distribution of Other Neuropeptides in Nematodes
A wide range of antisera to vertebrate and invertebrate neuropeptides has given positive immunostaining in nematode nervous systems (Sithigorngul et al., 1990; Brownlee et al., 1993a Brownlee et al., ,b, 1994 Halton et al., 1994) . The usefulness of the immunolocalization data to understanding of nematode neuropeptide systems is somewhat limited until the epitopes with which the antisera cross-react have been fully characterized. Nevertheless, of particular interest has been the localization of immunoreactivity to known insect neuropeptides in A. suum (Smart et al., 1993 (Smart et al., , 1995 . Such neuropeptides, which differ from those in mammals (presumably more so than those identified by their homology to mammalian neuropeptides), are likely to be more easily targeted by novel chemotherapies against parasitic forms. Such findings suggest that novel drugs that disrupt neuropeptide signalling in nematode and insect pests are a real possibility.
Neuropeptide Structure
The vast majority of neuropeptides that have been structurally characterized from nematodes are FaRPs. One other peptide, TKQELE, Davenport et al., 1988; Sithigorngul et al., 1990; Brownlee et al., 1993a Brownlee et al., ,b, 1994 Fellowes et al., 1999 Warbrick et al., 1992 Warbrick et al., 1992 Geary et al., unpublished observations Geary et al., 1995 has been structurally characterized from A. suum (Smart et al., 1992b) . TKQELE was identified using an antiserum raised against KGQELE, a fragment of rat chromogranin A, a prohormone that is expressed in the secretory granules of numerous mammalian neuroendocrine cells. This peptide has not been characterized from any other nematode species and its function is unknown. All other nematode neuropeptides that have been structurally characterized are FaRPs. The C. elegans genome sequence information has enabled the gene sequences of other putative neuropeptides to be identified. In this respect, there are at least 15 non-FaRP neuropeptide-like encoding genes in C. elegans (Bargmann, 1998) . However, in the absence of expression and functional data, their assignment as nematode neuropeptides remains equivocal. Indeed, all of the currently available data on nematode neuropeptide expression relates exclusively to FaRPs. All known nematode neuropeptides and candidate neuropeptides have been identified by two methods: isolation and structural characterization of the peptide itself; or by sequencing of the encoding gene and identification of putative products. Most of the available data on nematode neuropeptides have been generated from either C. elegans or A. suum.
A. suum neuropeptides
To date, 20 FaRPs have been structurally characterized from A. suum (Table 20. 3) Stretton, 1993, 1995; Davis and Stretton, 1996) . All of these peptides were isolated from acid methanol extracts of A. suum heads and tails (which include the circumpharyngeal and perianal ganglia) using reverse phase HPLC. All of these peptides were designated as Ascaris FaRPs, AFX, where X is a number given chronologically upon discovery, i.e. AF1 was the first Ascaris FaRP to be structurally characterized . One of these peptides (FDRDFMHFamide), designated AF17, falls outside the FaRP family specifications in that it possesses a C-terminal HFamide and lacks the signature RFamide motif.
Six of the A. suum FaRPs identified by direct purification and sequencing have been found to be co-encoded on a single gene, the apf-1 gene (Edison et al., 1997) . The occurrence of multiple-copy neuropeptide genes in invertebrates has been recognized for some time and is clearly a feature of Ascaris FaRP-encoding genes. This finding shows that single nematode neuropeptide genes can encode a range of related, but structurally unique, neuropeptides. It seems likely that multiple-encoded neuropeptides have arisen as the result of duplication events, and that over time these duplicated peptides have had the opportunity to mutate and assume alternative roles.
C. elegans neuropeptides
Most information on the neuropeptide complement of C. elegans has been derived from data generated by the genome sequencing consortium. Prior to this information, a single FaRP-encoding gene had been identified (Rosoff et al., 1992) . This gene was designated the FMRFamide-like peptide (flp)-1 gene and, like the neuropeptides, was appended a number chronologically upon discovery. With the completion of the C. elegans genome sequencing project, many more flp genes have been identified. To date, at least 18 C. elegans genes have been designated as flp genes and the expression of at least 15 of these has been confirmed using PCR methods (Nelson et al., 1998b) . Searches of the 'wormpep' facility in the C. elegans BLAST database, using known nematode C-terminal FaRP motifs, indicate the occurrence of at least three other putative FaRP-encoding genes. The identification of these genes and confirmation of their expression and their nomenclature assignments have been carried out by Li and co-workers (Boston University). The sequences of 62 different peptides are encoded on these genes, including KPNFMRYG (flp-1) and EDGNAPFGTMKFG (flp-3), which do not have the characteristic RFamide motif; thus, there are Stretton, 1993, 1995; Davis and Stretton, 1996) .
at least 60 known C. elegans FaRPs (Table 20 .4). The flp-1 gene was also characterized from the closely related species, C. vulgaris (Schinkmann and Li, 1994) . Interestingly, several of these peptides have been identified in other nematode species, including peptides encoded on genes flp-1, flp-6, flp-8, flp-11 and flp-14 . This points to a significant degree of conservation in nematode FaRP structure. Although such conservation of structure may be mirrored by conservation of function, this remains to be tested. Indeed, it seems plausible that those FaRPs that are the most structurally conserved across nematode species include those peptides that have important associated physiology; their key physiological role is likely to have inhibited structural divergence.
Other nematode neuropeptides
FaRPs have been structurally characterized from two other nematode species: the free-living nematode Panagrellus redivivus and the sheep gastrointestinal parasite Haemonchus contortus. Peptides identified from P. redivivus include: SDPNFLRFamide (PF1), SADPNFLRFamide (PF2) (Geary et al., 1992) ; KSAYMRFamide (PF3/AF8) (Maule et al., 1994a) ; KPNFIRFamide (PF4) (Maule et al., 1995a) ; KHEYLRFamide (AF2) (Maule et al., 1994b) ; and AMRNALVRFamide and NGAPQPFVRFamide (C. Moffett and N.J. Marks, unpublished observations). Of interest here is the fact that all but one (PF4) show complete identity with C. elegans peptides; PF4 only differs from the flp-1 peptide, KPNFLRFamide, by a single amino acid substitution (I 5 for L 5 ). Such commonality in FaRP structure may relate to evolutionary relatedness in these two species. However, H. contortus peptides include KSAYMRFamide (PF3/AF8) and KHEYLRFamide (AF2), which are present in all four species from which peptides have been structurally characterized (Keating et al., 1995; Marks et al., 1999a) . Clearly, some FaRPs are widely distributed across a broad range of nematode species. Another interesting observation is that AF2 was the most abundant FaRP in each of the species examined (C. elegans, P. redivivus, A. suum and H. contortus). Again, this may relate to a key role in nematode biology. It is worth noting that the most abundant neuropeptides in the brains of species as diverse as platyhelminths and humans are neuropeptide Y (NPY)-related peptides . Radioimmunometric analyses of nematodes have shown that AF2 cross-reacts with some NPY-family peptide antisera (Maule et al., 1994b) . This, coupled with the fact that there are no obvious NPY-family peptides in nematodes (none has been reported in the literature and scans of 'wormpep' in the C. elegans BLAST server reveal no hits using C-terminal motifs of known NPY-family peptides as search strings) yet cDNAs with homology to NPY-family receptors have been reported (deBono and Bargmann, 1998) Other putative flp genes were identified using search strings comprising C-terminal tetrapeptides of known FaRPs plus a C-terminal G (amide donor) residue in searches of the C. elegans BLAST server, wormpep 17. the role of AF2 in nematodes and the endogenous receptors with which it interacts is required before this possibility could be reasonably tested.
Neuropeptide Function
The rapid and relatively recent determination of the structures of so many nematode neuropeptides has resulted in a huge disparity between available structural and functional data; indeed, currently the physiological function of any of the known nematode neuropeptides remains unknown. Most of the accumulated data on nematode neuropeptide activities have been obtained using muscle strips of A. suum and, as a result, only provide a glimpse of the putative role for many of the peptides involved. With respect to the FaRPs, the fundamental problem in resolving physiological function in nematodes stems from the absence of expression data, i.e. where the peptides occur in the worm. Although numerous immunocytochemical studies have localized FaRP expression in a variety of nematodes (see earlier), the distribution of individual FaRPs is unknown. Moreover, the localization of specific receptors for each of the neuropeptides is needed to facilitate rational attempts to evaluate individual peptide roles. At present, no receptor for any of the known nematode neuropeptides has been identified. The identification of the receptors for each of the known neuropeptides and the evaluation of their function are the greatest and most important challenges to scientists working in this area.
The effects of known A. suum FaRPs
The first identified Ascaris FaRP, AF1 (KNEFIRFamide), and the structurally related peptide, AF2 (KHEYLRFamide), have been found to inhibit locomotory waves when injected into adult worms . Their effects on body-wall muscle strips are biphasic, comprising a transient relaxation followed by an extended period of increased contractile activity (Maule et al., 1995b; Bowman et al., 1996) . When using muscle strips that have had the motor nerve cords removed, only the inhibitory actions of AF1 and AF2 are seen (Maule et al., 1995b) . This suggests that the inhibitory phase is due to post-synaptic effects on body-wall muscle in the worm. In contrast, the excitatory effects are nerve-cord dependent and are not observed in muscle strips that have been denervated. Another possibility is that the peptides interact with receptors at the post-synaptic junction -these are also removed in specimens that have had the motor nerve cords removed.
One difference between the effects of AF1 and AF2 is their potency: AF2 is up to 1000-fold more potent than AF1. AF1 has been shown to inhibit both dorsal and ventral inhibitory motor neurones and decreases input resistance in the VI and DI motor neurones. The VI and DI motor neurones are believed to be the site of the excitatory AF1 receptor Davis and Stretton, 1996) . The inhibition of inhibitory motor neurones would be expected to result in an excitatory response. The effects of AF2 have also been shown to enhance the effects of the excitatory neurotransmitter, ACh, through the amplification of ACh-induced excitatory junction potentials (Pang et al., 1995) . AF2 has also been found to stimulate cAMP levels in A. suum body-wall tissue (D.P. Thompson, J.P. Davis and T.G. Geary, Pharmacia and Upjohn Co., 1996, personal communication). These effects do not fully explain the enhanced oscillatory activity of muscle strips exposed to these peptides.
Examination of the structure-activity relationships of AF1 and AF2 provide further evidence of complexity in this signalling system (Bowman et al., 1996) . Structural modifications in the form of alanine scan series (replacement of each residue in turn with alanine) and N-terminally truncated analogues of AF1 revealed that both the N-and C-termini were essential for biological activity. One of these analogues, KNEFIAFamide, was found to antagonize the effects of AF1 but not those of AF2. Furthermore, chimeras of AF1 and AF2 (KHEFIRFamide, KNEYIRFamide and KNEFLRFamide) had similar or reduced potencies to that of AF1. These findings suggest, but do not prove, that AF1 and AF2 act at different receptors in the worm.
Six known Ascaris FaRPs possess a C-terminal PGVLRFamide (AF3, AF4, AF10, AF13, AF14, AF20). All six of these peptides have been shown to have similar excitatory effects on body-wall muscle of Ascaris (Cowden and Stretton, 1995; Davis and Stretton, 1996) . Diversity in the N-terminal regions of peptides with a C-terminal PGVLRFamide motif seems to have no obvious effect on observed physiology. One of these peptides, AF3 (AVPGVLRFamide), has also been shown to have excitatory effects on the domestic fowl parasite, Ascaridia galli (Trim et al., 1997) . Further examination of the mechanism underlying the excitatory effects of AF3 revealed that its actions were independent of the endogenous cholinergic system (Trim et al., 1997) . Furthermore, AF3 decreased cAMP levels in both A. suum and A. galli and inhibited forskolin-stimulation of cAMP levels (Trim et al., 1998) . These results show that AF3 has similar effects on muscle contraction and cAMP levels in these two nematodes and points to at least some conservation of neuropeptide physiology across nematode species.
KSAYMRFamide (AF8) has been found to have nerve cord-dependent excitatory effects on ventral and inhibitory effects on dorsal muscle strips of A. suum (Maule et al., 1995b) . To date, this is the only peptide found to display differential activity on body-wall muscle of Ascaris. The segmental oscillator model of locomotion proposed for A. suum relies on reciprocal inhibition of opposing effects on dorsal and ventral muscle fields which, with the appropriate time intervals, result in the recognized nematode locomotory wave form (Stretton et al., 1985; Davis and Stretton, 1996) . It seems reasonable to hypothesize that AF8 could be involved in the coordination of locomotory behaviour, with simultaneous release on to dorsal and ventral muscles causing a ventral bend. No peptide that has an opposite effect has been identified.
There is a limited amount of information available on the actions of other endogenous A. suum FaRPs on body-wall muscle and on four classes of motor neurones. AF5 (SGKPTFIRFamide) was found to have excitatory effects on body-wall muscle and decreases the input resistance of the DE1, DE2, VI and DI motor neurones; AF7 (AGPRFIRFamide) had similar effects on the motor neurones (Davis and Stretton, 1996) . AF9 (GLGPRPLRFamide) and AF17 (FDRDFMHFamide) both increased muscle tension in body-wall muscle whereas AF6 (FIRFamide), AF11 (SDIGISEPNFLRFamide) and AF19 (AEGLSSPLIRFamide) decreased muscle tension (Davis and Stretton, 1996) . Also, AF11 decreased the input resistance of VI and DI motor neurones and increased the input resistance of DE1 and DE2 motor neurones. AF7 (AGPRFIRFamide) and AF16 (ILMRFamide) were found to have little effect on Ascaris body-wall muscle. The evaluation of the physiological role of each of the known Ascaris FaRPs and the localization of the specific receptors, as undertaken by workers in the Stretton laboratory (University of Wisconsin-Madison), is central to the understanding of this signalling system. Clearly, the variety of effects of endogenous Ascaris FaRPs on body-wall muscle and motor neurones points to a central role for these peptides in locomotory behaviour, with the involvement of a highly complex signalling system.
FaRPs have been implicated not only in the coordination/modulation of locomotory behaviour in Ascaris, but also in the activity of two other distinct muscle systems in the worm. The pharynx and the ovijector are highly developed muscular pumping organs involved in the intake and digestion of food and in the release of eggs, respectively. Both of these organs have a rich, well-developed peptidergic neuronal component (Brownlee et al., 1993a (Brownlee et al., , 1994 Fellowes et al., 1999) . When active, both the pharynx and the ovijector display waves of coordinated peristaltic activity that have been shown to be modulated by FaRPs. Pharyngeal pumping reponds to AF8 with an initial transient increase in activity followed by a period of inactivity (Brownlee et al., 1995) . The ovijector (also known as the vagina vera) displayed a variety of in vitro responses when exposed to AF1, AF2, AF3, AF4 or AF8 (Fellowes et al., 1998 (Fellowes et al., , 2000 . Thus, AF1 caused biphasic responses that comprised an initial contraction followed by a relaxation and a period of inactivity; AF2 and AF8 both reduced contractile activity in the ovijector; AF3 and AF4 had complex multiphasic effects on the ovijector that included a contraction followed by a period of increased activity and then inactivity. The fact that these peptides had distinguishable effects on the ovijector suggests that multiple receptors are present -a situation reminiscent of that seen with body-wall tissue. Clearly, the exact role of these peptides in the pharynx and ovijector are far from clear. Nevertheless, FaRP modulation of pharyngeal pumping and ovijector activity seem highly plausible hypotheses that warrant further evaluation, not least because these sites may well provide important focal points for drug action or drug entry into parasitic nematode species.
The effects of other nematode FaRPs
Not only are known endogenous Ascaris neuropeptides active on the worm, but also FaRPs from other species, which may or may not be found to occur in Ascaris, have potent and diverse effects on the muscle systems in the worm. Probably the best-characterized signalling system is that employed by PF1 (SDPNFLRFamide) and PF2 (SADPNFLRFamide). These two peptides, originally identified from P. redivivus (Geary et al., 1992) and C. elegans (Rosoff et al., 1992) , have potent nerve cord-independent, Ca 2+ -dependent inhibitory effects on dorsal and ventral body-wall muscle strips of A. suum (Franks et al., 1994; Bowman et al., 1995; Maule et al., 1995b) which cause a long-lasting flaccid paralysis of the tissue. The profound relaxation is accompanied by a small hyperpolarization coupled with no obvious input resistance change in the muscle cells of the body wall (Franks et al., 1994; Bowman et al., 1995) . The free radical gas nitric oxide (NO) has been implicated in the actions of PF1 due to the fact that inhibitors of NO synthase (NOS, the enzyme that generates NO) blunt PF1 effects in Ascaris muscle strip preparations. Furthermore, the NO donor, sodium nitroprusside, induced muscle strip relaxation similar to that seen with PF1 . NOS activity was highest and [ 3 H]PF1 binding was most pronounced in the Ascaris hypodermal layer; this layer lies closely associated with the body-wall muscle and surrounds the major nerve cords. This evidence suggests that NOS activity in the hypodermal layer results in the release of NO. NO could easily diffuse to the muscle, where it may act on an as yet unknown intracellular target to induce muscle relaxation. Whether or not this activity involves the stimulation of cytosolic guanylate cyclase and an increase in cytosolic cGMP levels, similar to that seen in the vascular epithelium of mammals, awaits investigation. Nevertheless, the evidence indicates a complex signalling pathway involving several tissue types in the worm and provides a glimpse of some of the nuances that may exist with FaRP signalling in nematodes.
PF1 and PF2 have also been found to modulate the contractile activity of the ovijector of A. suum (Fellowes et al., 2000) . PF1 and PF2 reduce the inherent contractile activity of the ovijector by an unknown mechanism. It is possible that this inhibitory activity, like that seen in the body wall, relies on NO.
Structure-activity studies with PF1 have indicated that N-terminally truncated and alanine-scan peptides have reduced inhibitory effects (des [Ser 1 ]-, des[Ser 1 Asp 2 ]-, Ala 1 -, Ala 2 -, Ala 3 -, Ala 4 -and Ala 6 -PF1) or are inactive (Ala 5 -, Ala 7 -and Ala 8 -PF1) . The pharmacological profiles of the nematode FaRPs will help to elucidate functional requirements for the individual peptides and may help to delineate receptor diversity (see later).
PF4 (KPNFIRFamide) has been found to induce nerve cordindependent and Cl − -dependent relaxation of Ascaris body-wall muscle strips and concomitant hyperpolarization of muscle cells (Maule et al., 1995b; Holden-Dye et al., 1997) . The relaxation induced by PF4 is much more rapid and short-lived than that seen with PF1. The classical nematode inhibitory-neurotransmitter, γ-aminobutyric acid (GABA), also acts directly on muscle to open Cl − channels and induce relaxation that is qualitatively similar to that caused by PF4. The possibility of interaction between GABA and PF4 was examined using the nematode GABA channel inhibitor, NCS 281-93. This compound reduced the effects of GABA but did not alter PF4-induced relaxation of Ascaris body-wall muscle (Maule et al., 1995b) . These results indicate the occurrence of PF4-receptors that are independent of the GABA receptor; the possibility remains that other receptor sub-types interact with both signalling molecules. Structureactivity studies on PF4 have revealed that removal of the proline residue from position 2 is detrimental to biological activity of the peptide (Kubiak et al., 1996) . PF4 has also been found to have profound inhibitory effects on the ovijector of A. suum (Fellowes et al., 2000) .
The C. elegans FaRP, APEASPFIRFamide, has been shown to have inhibitory effects on Ascaris body-wall muscle that are nerve cordindependent (Marks et al., 1997) . The ionic dependence of the effects of APEASPFIRFamide revealed that its actions could be distinguished from those of the other known inhibitory FaRPs, PF1, PF2 and PF4. Interestingly, the C. elegans FaRP, KPSFVRFamide, was found to have no observable effects on dorsal or ventral muscle strip preparations of the worm (Marks et al., 1999b) , even though the structurally related peptide PF4 (KPNFIRFamide) has potent inhibitory actions. However, the chimeric peptide KPNFVRFamide had similar inhibitory effects to those of PF4 whereas KPSFIRFamide was also inactive. It appears, therefore, that either the serine residue in position 3 of these peptides inhibits the activity or the asparagine residue in position 3 of PF4 is essential for the observed effects. In either case, at least some of the endogenous FaRP receptors have strict structural prerequisites on the ligands with which they interact. The ability for nematode FaRP receptors to delineate between different ligands would seem to be an essential requirement for receptors faced with such a complex array of signalling molecules.
FaRP effects on C. elegans
Detailed understanding of the development, cytology and now the genome of C. elegans has greatly promoted the value of this soil nematode. The complexity of the neuropeptidergic system in the worm is clearly evident from the genome data (see earlier). The ability to manipulate gene expression in C. elegans provides an extremely valuable tool in attempts to understand neuropeptide function in nematodes. C. elegans knockouts (those that have a deletion in a particular gene) for the neuropeptide gene flp-1 have been identified and characterized (Nelson et al., 1998a) . These studies revealed that disruption of the flp-1 gene causes a series of behavioural defects, including loopy and uncoordinated movement, hyperactivity and wandering, nose-touch insensitivity, absence of osmotic avoidance and absence of serotonin-induced inhibition of locomotion (Nelson et al., 1998a) . Evaluation of the effects of gene knockouts for each of the endogenous neuropeptide-encoding genes will provide valuable data on neuropeptide function in nematodes. As evidence of FaRP structural similarity between nematode species grows, so the relevance of the results obtained for C. elegans to nematodes in general increases.
FaRP effects on H. contortus
Isotonic muscle contraction was used to measure the effects of selected nematode FaRPs on the body-wall muscle of H. contortus. AF2 was found to have inhibitory effects on muscle activity and inhibited acetylcholine (ACh)-induced contractions in the worm whereas AF8 had excitatory effects on the muscle and enhanced ACh-induced contractions (Marks et al., 1999a) . There were obvious differences in the methodologies used to evaluate the effects of these peptides on Haemonchus muscle compared with those used to examine these peptide effects on Ascaris. How comparable the results are has yet to be determined.
Further studies using two different Haemonchus isolates to examine the effects of AF1 and AF8 provided evidence of some interaction between the FaRP and cholinergic signalling systems in the worm. The responses of a 'normal' worm isolate, which was sensitive to cholinomimetics including levamisole, were compared with the responses of an isolate (Lawes isolate), which had reduced sensitivity to cholinergic drugs (Marks et al., 1999a) . In these studies the Lawes isolate, which had reduced cholinomimetic sensitivity, was equally less sensitive to AF8, i.e. its dose-response curve for cholinomimetics and AF8 was shifted to the right relative to that seen in 'normal' worms. Other FaRP effects were identical in both isolates. Although the exact reasons for this are unknown, it is hypothesized that AF8 has its excitatory effects by enhancing worm muscle responses to ACh. One possibility is that AF8 acts presynaptically (as seems to be the case in A. suum) to induce the release of ACh such that worms from the Lawes isolate have a reduced response to cholinomimetics and signalling molecules, such as AF8, which act through this system. This hypothesis awaits experimental confirmation.
flp-Gene Expression and Processing
The sequencing of the C. elegans genome and in particular the identification of the multiple flp-encoding genes coupled with PCR techniques have made it possible to examine the transcribed products and developmental regulation. In a study by Nelson et al. (1998b) , reverse-transcribed RNA from mixed-stage worms was amplified with specific primers for each gene. The resulting amplification products were sub-cloned and their DNA sequences determined. By using this method the expression of the genes flp-1 through to flp-13 was confirmed in C. elegans. Previous studies had revealed that flp-1 may be alternatively spliced such that two different gene products, differing in one of the encoded peptides, are generated (Rosoff et al., 1992 (Rosoff et al., , 1993 . In subsequent studies, multiple PCR products were amplified from cDNA from flps-2 and 11, suggesting that these genes may also be alternatively spliced (Nelson et al., 1998b) . To examine the developmental expression of these genes, RNA was isolated from each stage of the C. elegans life cycle (eggs, L1, L2, L3, L4 and adult), reversetranscribed and amplified with specific primers for each gene. The results of these experiments revealed that amplification products from cDNA from all of the developmental stages, as well as adults, were present for flp genes 1-7 and 10-12. In the case of flp genes 8, 9 and 13, amplification products were obtained from each of the developmental stages but not from the adult nematode. The results indicate that FaRPs play an important role throughout the life cycle of C. elegans and that some of these peptides may have functions in specific stages of the nematode life cycle such that their expression is developmentally regulated.
Nematode Neuropeptide Receptors
At the time of writing, no neuropeptide ligand/neuropeptide receptor pair has been unequivocally characterized from a nematode. Many putative neuropeptide receptors have been identified by the genome sequencing project but little progress has been made on ligand identification, partly due to the difficulties in establishing a stable in vitro expression system suitable for ligand identification coupled with the isolation of sufficient ligand to facilitate structural characterization. The putative nematode neuropeptide receptors have been identified by their homology to known neuropeptide receptors, classically comprising seven-transmembrane domains and a G-protein coupling cytosolic segment. These receptors have a wide variety of activities mediated by G-protein interaction with, and regulation of, cytosolic proteins and enzymes. Although most of the known peptide receptors are G-protein coupled, the vast majority are endogenous to higher vertebrates and as such may not be representative of the situation in nematodes.
To date, two FaRP receptors have been characterized from molluscs: one from Helix aspersa that is a directly ligand-gated Na + channel (Lingueglia et al., 1995) and one from Lymnaea stagnalis that is a G-protein coupled receptor (GPCR) (Tensen et al., 1998) . This is significant as the occurrence of both types of FaRP receptors would increase the variety of potential responses; should this situation also occur in nematodes, then this is likely to be a factor in the often complex and diverse physiology observed for FaRPs in nematode tissues.
With the number of known nematode FaRPs exceeding 70, it is possible that each neuropeptide has a specific endogenous receptor. However, it seems more likely that there will not be a different receptor for every FaRP and that those peptides with certain stoichiometric characteristics will be able to interact with a particular receptor subtype. For example, the structurally similar FaRPs PF1 and PF2 have similar actions on both body-wall and ovijector muscle of A. suum such that it seems reasonable to assume that they interact with a common receptor; the same may be true for other groups of structurally related neuropeptides, including the A. suum PGVLRFamides encoded on afp-1. All of these have differing N-termini yet similar effects on body-wall muscle in the worm, suggesting that the N-termini are not critical for the observed physiology. This is in contrast to the different effects noted for peptides with the C-terminal PNFLRFamide motif, e.g. PF1 and PF4. In the latter, the N-terminal sequence profoundly alters the observed activity of the peptide, presumably by directing the ligand to interact with a different receptor.
Unfortunately, not enough is known about the activities and structureactivity requirements of each of the neuropeptides to estimate the number of receptors responsible for observed physiology. Nevertheless, some estimate of the potential number of receptors can be made from the genome sequence information in that over 50 peptide-GPCRs have been identified (Bargmann, 1998) . Since there are estimated to be in the order of 60 non-FaRP neuropeptides (Bargmann, 1998) and at least 62 FaRPs in C. elegans (Table 20 .4), it is evident that there is not a GPCR for each of these neuropeptides. Assuming there is no redundancy in the system whereby some of the encoded peptides have no specific function, then more than one neuropeptide may interact with at least some of the identified receptors. It is likely to be very difficult to determine the specific FaRP ligand for these receptors.
Evidence that at least some nematode FaRPs interact with GPCRs was generated by the fact that some G-protein subunit mutants displayed phenotypes similar to those of flp-1 knockouts (Nelson et al., 1998a) . A series of double mutant crosses for flp-1 and selected G-proteins indicated that peptides encoded on the flp-1 gene act upstream of G-proteins to control motor and sensory parameters (Nelson et al., 1998a) . On a cautionary note, since one of the two FaRP receptors characterized from molluscs is a directly ligand-gated ion channel, it is possible that at least some nematode neuropeptides may interact not with GPCRs but with ion channel proteins. Although it has been suggested that PF4 directly gates a Cl − -channel in A. suum muscle membranes, membrane-level studies are needed to confirm this hypothesis.
Recently, a C. elegans GPCR (designated npr-1) with homology to the NPY-family peptide receptors (designated Y receptors) has been identified and shown to influence social feeding behaviour in the worm (deBono and Bargmann, 1998) ; NPY in mammals has numerous actions including a role in appetite control. That related receptors influence feeding behaviour in C. elegans may reveal that this signalling system has been conserved both structurally and functionally in hugely divergent species. One major problem with this theory is that there are no obvious NPY-family peptides in nematodes (see earlier). Clearly, the examination of ligand-receptor relationships within the neuropeptidergic system of nematodes warrants greater attention.
Concluding Remarks
With nematode neuropeptides numbering in excess of 120, it is evident that the endogenous neuropeptide signalling system is highly developed and central to the functional biology of these worms. The potential for a vast array of intricate and complex signalling pathways, modulated or coordinated by neuropeptides, is apparent in nematodes. The capacity for neuropeptide interaction with other classical signalling pathways coupled to highly controlled expression patterns, including developmental regulation and differential splicing of neuropeptide genes, offers immense potential for complexity and adaptability in the nervous system. Although we are a very long way from understanding the processes involved in the neuropeptidic integration and modulation of nematode behaviour, C. elegans offers a unique opportunity for a greater understanding of neuropeptide biology. Undoubtedly, the neuropeptide system of these worms offers exciting potential, not only for the neurobiologist, but also for the parasitologist seeking magic bullets to help to control parasite disease. Reports of ever-increasing anthelmintic resistance demand scientific evaluation of more drug targets in worms. Although the neuropeptide system will undoubtedly offer opportunities for the development of novel chemotherapies, the question remains: how long this will take? Leverhulme Trust grant to N.J.M. and by a grant from the Pharmacia and Upjohn Company to A.G.M. and D.W.H.
